Advertisement
Advertisement

DSGN

DSGN logo

Design Therapeutics, Inc. Common Stock

15.62
USD
Sponsored
-0.17
-1.08%
May 13, 16:00 UTC -4
Closed
exchange

Pre-Market

15.12

-0.50
-3.23%

Design Therapeutics, Inc. Common Stock Profile

About

Design Therapeutics Inc. is a biotechnology company. It involved in developing a platform of gene targeted chimera small molecules for the treatment of serious degenerative disorders caused by inherited nucleotide repeat expansions. Design Therapeutics Inc. is based in CARLSBAD, Calif.

Info & Links

CEO

Pratik Shah

Headquarters

6005 HIDDEN VALLEY ROAD, SUITE 110
CARLSBAD, CA 92011, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.designtx.com

Auditor

Ernst & Young LLP

Share holders

11

Employees

54

Design Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

944.10M

Enterprise Value

927.24M

Enterprise Value/EBITDA(ttm)

-11.29

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

3.35

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-32.72%

Return on Invested Capital(ttm)

-32.77%

Return on Assets(ttm)

-31.08%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-82.10M

Net Income Available to Common(ttm)

-69.79M

Diluted EPS(ttm)

-1.22

Share Statistics

Beta (5Y Monthly)

1.57

52-Week Change

337.54%

S&P 500 52-Week Change

26.33%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

61.67M

Dividend Yield

0.00%

Float4

47.18M

% Held by Insiders

23.50%

% Held by Institutions

56.64%

Balance Sheet

Total Cash(mrq)

219.84M

Total Cash Per Share(mrq)

3.56

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

17.14%

Quick Ratio(mrq)

17.14%

Book Value Per Share(mrq)

3.52

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.95

Free Cash Flow(ytd)

-54.55M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement